MetLife Investment Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,223	Closed	-$93.6K	–	2808
2024 Q4	$93.6K	Hold	14,223	–	–	﹤0.01%	2651
2024 Q3	$129K	Buy	14,223 +7,803	+122%	+$70.5K	﹤0.01%	2526
2024 Q2	$103K	Buy	6,420 +599	+10%	+$9.61K	﹤0.01%	2591
2024 Q1	$91.3K	Buy	+5,821	New	+$91.3K	﹤0.01%	2578